CoChat

Prophylactic use of anti‐emetic medications reduced nausea and vomiting associated with exenatide treatment: a retrospective analysis of an open‐label, parallel‐group, single‐dose study in healthy subjects

Open access
Ellero, C., Han, J., Bhavsar, S., Cirincione, B. B., DeYoung, M. B., Gray, A. L., Yushmanova, I., Anderson, P. W. · 2010 · Diabetic Medicine
Cited by 35

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Diabet. Med. 27, 1168–1173 (2010) Aims Transient nausea and, to a lesser extent, vomiting are common adverse effects of exenatide that can be mitigated by dose titration and usually do not result in treatment discontinuation. This retrospective analysis of data from a phase 1, open‐label, parallel‐group, single‐dose study in healthy subjects evaluated the effect of oral anti‐emetics on exenatide‐associated nausea and vomiting and on the pharmacokinetics of exenatide. Methods A single subcutaneous dose (10 μg) of exenatide was administered to 120 healthy subjects (19–65 years, BMI 23–35 kg/m 2). Incidences of nausea and vomiting were compared between 60 subjects premedicated with two oral anti‐emetics 30 min before the exenatide dose and 60 non‐premedicated subjects. Similarly, the area under the concentration‐time curve (AUC) and the maximum observed concentration (C max) of plasma exenatide concentrations over 8 h post‐dose were compared. Results Among all subjects [61% male, 32 ± 12 years, body mass index (BMI) 29.1 ± 3.4 kg/m 2 (mean ± sd)], mild to moderate nausea was the most frequent adverse event after exenatide dosing. Vomiting was also observed. Subjects premedicated with anti‐emetics experienced significantly less nausea and vomiting (16.7 and 6.7%, respectively) vs. non‐premedicated subjects (61.7 and 38.3%, respectively; P‐value < 0.0001 for both nausea and vomiting). The mean area under the concentration‐time curve and the maximum observed concentration AUC and C max of plasma exenatide concentrations during 8 h post‐dose were not significantly different between groups. Conclusion Administration of oral anti‐emetics before a single 10‐μg exenatide dose was associated with significant reductions in treatment‐emergent nausea and vomiting, with no discernible effect on the pharmacokinetics of exenatide. Use of anti‐emetic therapy may provide a short‐term strategy to minimize the nausea and vomiting associated with exenatide treatment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1464-5491.2010.03085.x

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 35

Metadata

Authors
Ellero, C., Han, J., Bhavsar, S., Cirincione, B. B., DeYoung, M. B., Gray, A. L., Yushmanova, I., & Anderson, P. W.
Venue
Diabetic Medicine
Publisher
Wiley
Published
2010-07-05
Volume
27
Issue
10
Pages
1168-1173
ISSN
  • 0742-3071 (ISSN-L)
  • 1464-5491
OpenAlex
W1562274230
Cited by
35
References
5
FWCI
2.79
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prophylactic use of anti‐emetic medications reduced nausea and vomiting associated with exenatide treatment: a retrospective analysis of an open‐label, parallel‐group, single‐dose study in healthy subjects. https://app.cochat.ai/papers/10.1111/j.1464-5491.2010.03085.x
The paper
Ellero, C., Han, J., Bhavsar, S., Cirincione, B. B., DeYoung, M. B., Gray, A. L., Yushmanova, I., & Anderson, P. W. (2010). Prophylactic use of anti‐emetic medications reduced nausea and vomiting associated with exenatide treatment: a retrospective analysis of an open‐label, parallel‐group, single‐dose study in healthy subjects. Diabetic Medicine. https://doi.org/10.1111/j.1464-5491.2010.03085.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.